Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S1222 Ph. III Randomized Trial of fulvestrant +/- exemestane +/- everolimus in HR+ postmenopausal Stage IV 5/9/2014 10/15/2015 4%
    Closed S1203 PIII 7+3 vs IA vs IA+vorinostat for AML 12/15/2012 11/4/2015 96%
    Closed S1400A Lung-MAP S1400A: Non-Match, MEDI4736 6/15/2014 11/18/2015 83%
    Closed S0905 Ph I / Randomized Ph II Mesothelioma Cediranib 3/15/2010 2/15/2016 91% Published
    Closed S1406 Rano Ph II of Irino+Cetuximab +/- Vemurafenib in BRAF mutant mCRC 11/13/2014 4/1/2016 100%
    Closed S1304 RPII Dex + High or Low Dose Carfilzomib for R/R MM 10/18/2013 5/15/2016 100%
    Closed S1001 Phase II Early Stage DLBCL 7/18/2011 6/1/2016 100%
    Closed S1300 Rand Ph II of Crizotinib + Pem vs Pem in ALK+ NSCLC Pts Progressing Post Crizotinib 8/1/2014 9/1/2016 1%
    Closed S0931 Adjuvant Renal Cell, Everolimus vs Placebo, Ph III 4/1/2011 9/15/2016 100%
    Closed S1013 EGFR Skin Toxicity Validation 11/15/2011 10/1/2016 94%
    Closed S1400D Lung-MAP S1400D: FGFR - AZD4547 6/15/2014 10/31/2016 81%
    Closed S1400B Lung-MAP S1400B: PI3K - GDC-0032 6/15/2014 12/12/2016 57%
    Closed S1204 Viral Screening Study 8/29/2013 2/15/2017 100%
    Closed S1011 Muscle-Invasive Bladder Ca, Std vs Ext PLND, Ph III 8/1/2011 4/15/2017 100%
    Closed S1216 Metastatic Prostate Cancer, Phase III ADT+TAK-700 vs. ADT+Bicalutamide 3/1/2013 7/15/2017 100%
    Closed S0919 Phase II Idarubicin/AraC + Pravastatin for Relapsed AML 8/15/2009 9/15/2017 100%
    Closed S1314 Phase II COXEN Trial for Localized Bladder Cancer 7/9/2014 12/1/2017 100%
    Closed S1507 Ph II Tram + doce with kras NSCLC + and PD 7/18/2016 3/15/2018 100%
    Closed S1403 Lung Ph II/III Stage IV NSCLC Afatinib+Cetuximab vs Afatinib 3/25/2015 4/23/2018 29%
    Closed S1400I Lung-MAP S1400I: Non-Match, Nivolumab + Ipilimumab 12/18/2015 4/23/2018 79%
    Scroll Table